Application 212769
- Type
- ANDA
- Sponsor
- HIKMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUCRALFATE | SUCRALFATE | SUSPENSION;ORAL | 1GM/10ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212769-001 | SUCRALFATE | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-07-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-07-23 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-07-23 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-07-23 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-07-23 | 79d66fd596c7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212769-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | 2024-07-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212769-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212769-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212769-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A212769-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212769-001 | AB | 1 | 79d66fd596c7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sucralfate | SUCRALFATE | NuCare Pharmaceuticals,Inc. | 0206d7fa-a1d5-35d9-e063-6294a90a5eb3 | 2025-01-03 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Advanced Rx of Tennessee, LLC | b39f22c8-f224-451a-e053-2995a90aaad7 | 2024-12-31 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Advanced Rx Pharmacy of Tennessee, LLC | d3c41720-7e1a-08c1-e053-2a95a90aba03 | 2024-12-31 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Advanced Rx Pharmacy of Tennessee, LLC | f15fbb45-4406-0d32-e053-2995a90a40c5 | 2024-12-31 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Cosette Pharmaceuticals, Inc. | 3054ce94-78a2-4da4-8b14-95311b412ab2 | 2024-11-25 | Warnings, Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE ORAL | Amneal Pharmaceuticals LLC | 4350b771-76a9-4e00-93f0-a18c71288f83 | 2024-10-30 | Warnings, Adverse reactions | Sucralfate |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | a068e818-8da3-4f0d-88e0-acc88e76f3aa | 2024-08-22 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | NuCare Pharmaceuticals,Inc. | a40e43d4-9240-34ad-e053-2995a90a98e1 | 2024-07-15 | Adverse reactions | Sucralfate SUCRALFATE |
| Carafate | SUCRALFATE | Allergan, Inc. | c87c6b50-6977-4fa7-ae98-40c0753f7aee | 2024-05-21 | Adverse reactions | SUCRALFATE |
| Sucralfate | SUCRALFATE | Proficient Rx LP | 51459cdb-a04a-49c2-8ee4-8f234f522476 | 2024-05-01 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Golden State Medical Supply, Inc. | 15ad28fa-81ac-66d1-e063-6394a90aa3ea | 2024-04-09 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Advanced Rx Pharmacy of Tennessee, LLC | 138f0929-caad-56c6-e063-6294a90a55ef | 2024-03-13 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Amneal Pharmaceuticals NY LLC | b2e07ac7-4a8a-4b68-bb65-167d1aa86883 | 2024-03-01 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 28d7d257-8545-4b9f-8412-8ba144502400 | 2024-02-23 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Pacific Pharma, Inc. | 7407c58e-766f-4e93-a1bb-c77892ae0174 | 2024-02-10 | Warnings, Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 7b05323d-4695-41d7-8236-1e7b4e8f2a1e | 2024-01-11 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 25ae2ebc-a7e0-4fc9-a8d1-07f7dd7138e5 | 2024-01-11 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Proficient Rx LP | a42c5f3d-85f1-485b-91e6-58c25b3ddc71 | 2024-01-01 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | Amneal Pharmaceuticals NY LLC | a4f722e7-2885-4f27-8358-9c662439600a | 2023-12-30 | Adverse reactions | Sucralfate SUCRALFATE |
| Sucralfate | SUCRALFATE | American Health Packaging | e4761fb2-6a1a-44de-9d27-f6addabc24c8 | 2023-08-10 | Warnings, Adverse reactions | Sucralfate SUCRALFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.